MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma.

<h4>Background</h4>The metastasis-associated in colon cancer 1 gene (MACC1) has been found to be associated with cancer development and progression. The aim of this study was to investigate the prognostic value of MACC1 in early-stage and AFP-normal hepatocellular carcinoma (HCC).<h4&...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chan Xie, Jueheng Wu, Jingping Yun, Jiaming Lai, Yunfei Yuan, Zhiliang Gao, Mengfeng Li, Jun Li, Libing Song
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/2f3e1d72868c4fb8b1ba01aef2939cba
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2f3e1d72868c4fb8b1ba01aef2939cba
record_format dspace
spelling oai:doaj.org-article:2f3e1d72868c4fb8b1ba01aef2939cba2021-11-18T07:44:23ZMACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma.1932-620310.1371/journal.pone.0064235https://doaj.org/article/2f3e1d72868c4fb8b1ba01aef2939cba2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23717574/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>The metastasis-associated in colon cancer 1 gene (MACC1) has been found to be associated with cancer development and progression. The aim of this study was to investigate the prognostic value of MACC1 in early-stage and AFP-normal hepatocellular carcinoma (HCC).<h4>Methods</h4>mRNA and protein levels of MACC1 expression in one normal liver epithelial cells THLE3 and 15 HCC cell lines were examined using reverse transcription-PCR and Western blot. MACC1 expression was also comparatively studied in 6 paired HCC lesions and the adjacent non-cancerous tissue samples. Immunohistochemistry was employed to analyze MACC1 expression in 308 clinicopathologically characterized HCC cases. Statistical analyses were applied to derive association between MACC1 expression scores and clinical staging as well as patient survival.<h4>Results</h4>Levels of MACC1 mRNA and protein were higher in HCC cell lines and HCC lesions than in normal liver epithelial cells and the paired adjacent noncancerous tissues. Significant difference in MACC1 expression was found in patients of different TNM stages (P<0.001). Overall survival analysis showed that high MACC1 expression level correlated with lower survival rate (P = 0.001). Importantly, an inverse correlation between MACC1 level and patient survival remained significant in subjects with early-stage HCC or with normal serum AFP level.<h4>Conclusions</h4>MACC1 protein may represent a promising biomarker for predicting the prognosis of HCC, including in early-stage and AFP-normal patients.Chan XieJueheng WuJingping YunJiaming LaiYunfei YuanZhiliang GaoMengfeng LiJun LiLibing SongPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 5, p e64235 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Chan Xie
Jueheng Wu
Jingping Yun
Jiaming Lai
Yunfei Yuan
Zhiliang Gao
Mengfeng Li
Jun Li
Libing Song
MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma.
description <h4>Background</h4>The metastasis-associated in colon cancer 1 gene (MACC1) has been found to be associated with cancer development and progression. The aim of this study was to investigate the prognostic value of MACC1 in early-stage and AFP-normal hepatocellular carcinoma (HCC).<h4>Methods</h4>mRNA and protein levels of MACC1 expression in one normal liver epithelial cells THLE3 and 15 HCC cell lines were examined using reverse transcription-PCR and Western blot. MACC1 expression was also comparatively studied in 6 paired HCC lesions and the adjacent non-cancerous tissue samples. Immunohistochemistry was employed to analyze MACC1 expression in 308 clinicopathologically characterized HCC cases. Statistical analyses were applied to derive association between MACC1 expression scores and clinical staging as well as patient survival.<h4>Results</h4>Levels of MACC1 mRNA and protein were higher in HCC cell lines and HCC lesions than in normal liver epithelial cells and the paired adjacent noncancerous tissues. Significant difference in MACC1 expression was found in patients of different TNM stages (P<0.001). Overall survival analysis showed that high MACC1 expression level correlated with lower survival rate (P = 0.001). Importantly, an inverse correlation between MACC1 level and patient survival remained significant in subjects with early-stage HCC or with normal serum AFP level.<h4>Conclusions</h4>MACC1 protein may represent a promising biomarker for predicting the prognosis of HCC, including in early-stage and AFP-normal patients.
format article
author Chan Xie
Jueheng Wu
Jingping Yun
Jiaming Lai
Yunfei Yuan
Zhiliang Gao
Mengfeng Li
Jun Li
Libing Song
author_facet Chan Xie
Jueheng Wu
Jingping Yun
Jiaming Lai
Yunfei Yuan
Zhiliang Gao
Mengfeng Li
Jun Li
Libing Song
author_sort Chan Xie
title MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma.
title_short MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma.
title_full MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma.
title_fullStr MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma.
title_full_unstemmed MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma.
title_sort macc1 as a prognostic biomarker for early-stage and afp-normal hepatocellular carcinoma.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/2f3e1d72868c4fb8b1ba01aef2939cba
work_keys_str_mv AT chanxie macc1asaprognosticbiomarkerforearlystageandafpnormalhepatocellularcarcinoma
AT juehengwu macc1asaprognosticbiomarkerforearlystageandafpnormalhepatocellularcarcinoma
AT jingpingyun macc1asaprognosticbiomarkerforearlystageandafpnormalhepatocellularcarcinoma
AT jiaminglai macc1asaprognosticbiomarkerforearlystageandafpnormalhepatocellularcarcinoma
AT yunfeiyuan macc1asaprognosticbiomarkerforearlystageandafpnormalhepatocellularcarcinoma
AT zhilianggao macc1asaprognosticbiomarkerforearlystageandafpnormalhepatocellularcarcinoma
AT mengfengli macc1asaprognosticbiomarkerforearlystageandafpnormalhepatocellularcarcinoma
AT junli macc1asaprognosticbiomarkerforearlystageandafpnormalhepatocellularcarcinoma
AT libingsong macc1asaprognosticbiomarkerforearlystageandafpnormalhepatocellularcarcinoma
_version_ 1718423026318442496